Caroline B. Moore

2.0k total citations
12 papers, 997 citations indexed

About

Caroline B. Moore is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Caroline B. Moore has authored 12 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in Caroline B. Moore's work include Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (8 papers) and Asthma and respiratory diseases (3 papers). Caroline B. Moore is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (8 papers) and Asthma and respiratory diseases (3 papers). Caroline B. Moore collaborates with scholars based in United Kingdom, United States and Austria. Caroline B. Moore's co-authors include David W. Denning, Paul Bowyer, Marcin G. Fraczek, Steven Park, David S. Perlin, Susan J. Howard, Caroline Baxter, Ranjith Rajendran, Riina Rautemaa and Gordon Ramage and has published in prestigious journals such as Clinical Infectious Diseases, CHEST Journal and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Caroline B. Moore

12 papers receiving 987 citations

Peers

Caroline B. Moore
Ahmed S. Bueid Saudi Arabia
Jochem B. Buil Netherlands
Amy M. Kelaher United States
Lea Gregson United Kingdom
Judith Kuijpers Netherlands
David Angulo United States
Caroline B. Moore
Citations per year, relative to Caroline B. Moore Caroline B. Moore (= 1×) peers Jan W. M. van der Linden

Countries citing papers authored by Caroline B. Moore

Since Specialization
Citations

This map shows the geographic impact of Caroline B. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline B. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline B. Moore more than expected).

Fields of papers citing papers by Caroline B. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline B. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline B. Moore. The network helps show where Caroline B. Moore may publish in the future.

Co-authorship network of co-authors of Caroline B. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline B. Moore. A scholar is included among the top collaborators of Caroline B. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline B. Moore. Caroline B. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Moore, Caroline B., et al.. (2023). Risk factors associated with an outbreak of equine coronavirus at a large farm in North Carolina. Frontiers in Veterinary Science. 10. 1060759–1060759. 3 indexed citations
2.
Baxter, Caroline, Caroline B. Moore, Andrew Jones, A.K. Webb, & David W. Denning. (2013). IgE-Mediated Immune Responses and Airway Detection of Aspergillus and Candida in Adult Cystic Fibrosis. CHEST Journal. 143(5). 1351–1357. 69 indexed citations
3.
Fraczek, Marcin G., Michael Bromley, Caroline B. Moore, et al.. (2013). The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus . Journal of Antimicrobial Chemotherapy. 68(7). 1486–1496. 229 indexed citations
4.
Moore, Caroline B., et al.. (2012). High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates. Journal of Antimicrobial Chemotherapy. 68(3). 512–514. 61 indexed citations
5.
Harrison, Elizabeth, Ashutosh Singh, J.A. Morris, et al.. (2012). Mannose‐binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis. International Journal of Immunogenetics. 39(3). 224–232. 29 indexed citations
6.
Denning, David W., Steven Park, Cornelia Lass‐Flörl, et al.. (2011). High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease. Clinical Infectious Diseases. 52(9). 1123–1129. 241 indexed citations
7.
Felton, Timothy, Caroline Baxter, Caroline B. Moore, et al.. (2010). Efficacy and Safety of Posaconazole for Chronic Pulmonary Aspergillosis. Clinical Infectious Diseases. 51(12). 1383–1391. 109 indexed citations
8.
Pasqualotto, Alessandro C., Susan J. Howard, Caroline B. Moore, & David W. Denning. (2007). Flucytosine therapeutic monitoring: 15 years experience from the UK. Journal of Antimicrobial Chemotherapy. 59(4). 791–793. 38 indexed citations
9.
Howard, Susan J., Ian Webster, Caroline B. Moore, et al.. (2006). Multi-azole resistance in Aspergillus fumigatus. International Journal of Antimicrobial Agents. 28(5). 450–453. 157 indexed citations
10.
Hope, William, George L. Drusano, Caroline B. Moore, et al.. (2006). Effect of Neutropenia and Treatment Delay on the Response to Antifungal Agents in Experimental Disseminated Candidiasis. Antimicrobial Agents and Chemotherapy. 51(1). 285–295. 32 indexed citations
11.
Moore, Caroline B.. (2003). Comparison of three methods for in vitro susceptibility testing of Candida species with flucytosine. Journal of Antimicrobial Chemotherapy. 51(2). 297–304. 7 indexed citations
12.
Moore, Caroline B., Derek Law, & David W. Denning. (1993). In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergilus spp.. Journal of Antimicrobial Chemotherapy. 32(6). 831–836. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026